Innovative treatments could be useful in preventing and treating diabetic nephropathy by modulating the underlying inflammatory process: A new field of research may be a challenge for SGLT-2 inhibitors or GLP-1 agonists and so forth. This evidence concerns the gene GLP1R and diabetic kidney disease.